ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

PBH vs BHVN // OPTIONS IMPLIED MOVE & PUT/CALL SKEW

Prestige Consumer Healthcare Inc. (NYSE) VS. Biohaven Ltd. (NYSE) • 15-METRIC TALLY: PBH 3 — BHVN 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PBH VS. BHVN) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC PBH BHVN SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 54.70% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 13.80% -35.00% +48.80 PBH /roic <GO>
EV/EBITDA & P/E Valuation 7.0x — — TIE /valuation <GO>
Free Cash Flow Yield 10.67% -24.50% +35.17 PBH /fcf-yield <GO>
Operating Margin 28.40% — — TIE /operating-margins <GO>
Net Profit Margin 17.50% — — TIE /net-margins <GO>
Revenue Growth (YoY) -4.30% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 2.21 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 6/9 3/9 +3.00 PBH /piotroski-score <GO>
Options Implied Move & Put/Call Skew ACTIVE — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 54.0 58.4 -4.40 BHVN /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 11.3x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $2.32B $2.33B -$5.1M BHVN /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR PBH REV BHVN REV PBH GROSS % BHVN GROSS % PBH FCF BHVN FCF
FY 2025 $1.09B $2.09B 54.7% — $246.4M -$610.2M
FY 2024 $1.14B $2.48B 55.8% — $243.3M -$586.5M
FY 2023 $1.13B $1.22B — — $248.9M -$331.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PBH // BETA —
BHVN // BETA —